Targeting the Central Nervous System (CNS): A Review of Rabies Virus-Targeting Strategies

Molecular Pharmaceutics
Mira OswaldAchim Goepferich

Abstract

The transport of drugs across the blood-brain barrier is challenging. The use of peptide sequences derived from viruses with a central nervous system (CNS) tropism is one elegant option. A prominent example is the rabies virus glycopeptide-29 (RVG-29), which is said to enable a targeted brain delivery. Although the entry mechanism of the rabies virus into the CNS is very well characterized, it is unknown whether RVG-29-functionalized drug delivery systems (DDSs) follow this pathway. RVG-29-functionalized DDSs present themselves with modifications of the RVG-29 peptide sequence and different physicochemical properties compared to the rabies virus. To our surprise, the impact of these changes on the functionality is completely neglected. This review explores virus-related CNS-targeting strategies by comparing RVG-29-functionalized DDSs with regard to their peptide modification, physiochemical properties and their behavior in cell culture studies with a special focus on the original pathway of rabies virus entry into the CNS.

References

May 1, 1979·Journal of Neuropathology and Experimental Neurology·H Tsiang
May 1, 1991·The Journal of General Virology·H TsiangE Lycke
Apr 1, 1990·Journal of Molecular Recognition : JMR·T L Lentz
Jan 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·B DietzscholdH Koprowski
Oct 1, 1981·The Journal of General Virology·H D WatsonA L Smith
Jan 8, 1982·Science·T L LentzG H Tignor
Oct 6, 1997·Journal of Virology·M I ThoulouzeM Lafon
Aug 8, 1998·Journal of Virology·M I ThoulouzeM Lafon
Jul 13, 2000·Journal of Medicinal Chemistry·E J BilskyR Polt
Oct 12, 2000·Journal of Virology·H RauxD Blondel
Oct 12, 2000·Journal of Virology·Y JacobN Tordo
Jan 5, 2005·Proceedings of the National Academy of Sciences of the United States of America·Regina TugyiFerenc Hudecz
Jan 15, 2005·Progress in Neurobiology·C Gotti, F Clementi
Apr 5, 2005·Journal of Neurovirology·Monique Lafon
Aug 3, 2005·Medicinal Research Reviews·Robin PoltCharles M Keyari
Nov 26, 2005·Critical Reviews in Neurobiology·Keith T LePageThomas F Murray
Jul 6, 2007·Nature·Edouard M Cantin, John J Rossi
Oct 12, 2007·Journal of Virology·Christine TuffereauMartin Koltzenburg
Oct 12, 2007·Journal of Virology·Yvonne KlingenStefan Finke
Feb 16, 2008·Bioconjugate Chemistry·Younggyu KimShimon Weiss
Jul 8, 2008·Nature Reviews. Microbiology·Kwang Sik Kim
Aug 30, 2008·The AAPS Journal·Françoise HervéJean-Michel Scherrmann
May 23, 2009·PLoS Pathogens·Sara SalinasEric J Kremer
Jun 13, 2009·Vaccine·Mehdi Houimel, Koussay Dellagi
Jul 7, 2009·Future Virology·Bernhard DietzscholdMatthias Schnell
Dec 1, 2009·Nature Reviews. Microbiology·Matthias J SchnellAmy Papaneri
Dec 17, 2009·Journal of Neuroscience Methods·Gabriella Ugolini
Mar 11, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sang-Soo KimN Manjunath

❮ Previous
Next ❯

Citations

Jan 19, 2019·Biomaterials Science·Zhuxuan JiangChangyou Zhan
Oct 9, 2018·Journal of Drug Targeting·Shoshy MizrahyDan Peer
May 21, 2019·Expert Opinion on Drug Delivery·Behzad JafariYadollah Omidi
Aug 3, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rien RitawidyaMatthias Scheunemann
Aug 23, 2020·Nanomaterials·Sangiliyandi GurunathanHyuk Song
Jan 18, 2019·Advances in Pharmacological Sciences·Mahmoud GharbaviAli Sharafi
Jun 28, 2019·International Journal of Molecular Sciences·Rana Abdul RazzakFrank J Gunn-Moore
Jun 20, 2020·Beilstein Journal of Nanotechnology·Sonia M LombardoNazende Günday Türeli
Nov 16, 2019·Biomaterials Science·Yao-Xing ChenXiao-Ling Gao
May 6, 2020·International Journal of Nanomedicine·Nilmary Grafals-RuizPablo E Vivas-Mejía
Sep 26, 2019·Neural Regeneration Research·Rachel KeryGregory W Kirschen
Apr 19, 2020·Molecular Diagnosis & Therapy·Bhaskar RoyYogesh Dwivedi
Dec 19, 2020·Pharmaceutics·Seigo Kimura, Hideyoshi Harashima
May 16, 2020·Materials Science & Engineering. C, Materials for Biological Applications·Lu Chen, Jiangong Liang
Mar 27, 2021·International Journal of Biological Macromolecules·Cameron WellsLezanne Ooi
Oct 27, 2020·Current Topics in Medicinal Chemistry·Josep GarciaMeritxell Teixidó
Nov 4, 2021·Drug Delivery and Translational Research·Mireya L Borrajo, María José Alonso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.